文献速递脑血管病神经重症与神经感染

女性在脑出血试验中代表性不足的原因

Why Are Women Less Represented in Intracerebral Hemorrhage Trials?
PubMed 文献 · Stroke · 2021-01-25

本研究分析iDEF试验筛选失败记录,女性占参与者38.2%,女性筛选失败率45.7%高于男性54.3%(P<0.0001)。女性因年龄>80岁被排除比例22.40%高于男性12.61%(校正P=0.0007)。无法获取同意或拒绝参与比例无性别差异,提示选择偏倚可能性小,女性入组率低可能与年龄较大有关。

要点

  • 女性在iDEF试验中仅占38.2%。
  • 女性因年龄>80岁被排除的比例显著高于男性。
  • 无法获取同意或拒绝参与比例无性别差异。

核心结论

  • 女性入组率低可能归因于年龄较大,而非选择偏倚。

主要发现

  • 女性占iDEF试验参与者的38.2%。
  • 女性筛选失败率45.7%高于男性54.3%(P<0.0001)。
  • 女性因年龄>80岁被排除比例22.40%高于男性12.61%(校正P=0.0007)。
  • 现有不复苏/不插管状态排除比例女性3.69% vs 男性2.83%(校正P=0.067)。
  • 无法获取同意比例女性1.28% vs 男性1.73%(P=0.1),患者或家属拒绝比例女性1.26% vs 男性1.31%(P=0.9)。

临床怎么用

  • 未来脑出血试验可考虑放宽年龄上限以改善女性代表性。

局限性

  • 研究结果需在其他脑出血试验中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Fewer women than men tend to be enrolled in clinical trials of intracerebral hemorrhage. It is unclear whether this reflects lower prevalence of intracerebral hemorrhage in women, selection bias, or poor recruitment efforts. We undertook this study to examine differences between men and women in the reasons for exclusion from the iDEF trial (Intracerebral Hemorrhage Deferoxamine). METHODS: The screen failure log included 29 different reasons for exclusion. Chi-square statistics were used to evaluate the differences in reasons for exclusion between men and women. RESULTS: A total of 38.2% of participants in iDEF were women. Three thousand nine hundred eighty-two women (45.7%) and 4736 men (54.3%) were screen failures (P<0.0001). Similar proportions of women (1.28%) and men (1.73%) were excluded due to inability to obtain consent (P=0.1). Patients or families declined participation in 1.26% of women versus 1.31% of men (P=0.9). More women than men failed screening because of age>80 (22.40% versus 12.61%; adjusted P=0.0007) and preexisting do-not-resuscitate/do-not-intubate (3.69% versus 2.83%; adjusted P=0.067). CONCLUSIONS: Lower rates of women enrollment in the iDEF trial may be attributed to older age. Inability to obtain consent or declining participation was similar between women and men, arguing against selection bias. Our findings should be confirmed in other intracerebral hemorrhage trials to determine best strategies to improve women's representation in future trials.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Greige T, Norton C, Foster LD, et al. Why Are Women Less Represented in Intracerebral Hemorrhage Trials? Stroke. 2021. PMID: 33493043. doi:10.1161/STROKEAHA.120.032166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。